EUA
KPMAS COVID-19 Test
FDA Emergency Use Authorization · Kaiser Permanente Mid-Atlantic States · Jan 13, 2022
Key facts
| Product | KPMAS COVID-19 Test |
|---|---|
| Company | Kaiser Permanente Mid-Atlantic States |
| Product type | Real-time RT-PCR, Home Collection, Screening, Multiple Targets |
| Date | Jan 13, 2022 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: